All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
Follistatin 344
For educational and research purposes only. Not medical advice.
Follistatin 344 inhibits myostatin, removing the natural limit on muscle growth. Gene therapy trials for muscular dystrophy show promise. Injectable peptide form has limited but intriguing human data. Significant concerns about cardiac effects with long-term use.
Best Time
Post-workout or before bed
Method
subcutaneous
Frequency
Daily for loading, then maintenance
Half-life
~8-10 hours
Cycle Length
10-30 day loading, then maintenance
Storage
Refrigerate at 2-8°C. Extremely sensitive to temperature.
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
Drug testing and analysis 11 (11-12) :1675-1697 · 2019-11-01
Drug testing and analysis 12 (10) :1522-1533 · 2020-10-01
Mechanism of Action
Binds and neutralizes myostatin (a muscle growth inhibitor) and activin. Removal of myostatin's brake allows unchecked muscle hypertrophy and enhances muscle regeneration.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.